AP1930A - Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it - Google Patents

Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it

Info

Publication number: AP1930A
Authority: AP; ARIPO
Prior art keywords: preparation; pharmaceutical compositions; crystalline form; compositions containing; strontium ranelate
Prior art date: 2004-09-30

Application number

AP2005003323A

Other languages

English (en)

Other versions

AP2005003323A0 (en

Inventor

Stephanie Horvath

Isabelle Demuynck

Gerard Damien

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-30

Filing date

2005-05-31

Publication date

2008-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34942420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP1930(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-31 Application filed by Servier Lab filed Critical Servier Lab

2005-06-30 Publication of AP2005003323A0 publication Critical patent/AP2005003323A0/xx

2008-12-15 Application granted granted Critical

2008-12-15 Publication of AP1930A publication Critical patent/AP1930A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Fodder In General (AREA)
Steroid Compounds (AREA)

AP2005003323A 2004-09-30 2005-05-31 Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it AP1930A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0410335A FR2875807B1 (fr)	2004-09-30	2004-09-30	Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number	Publication Date
AP2005003323A0 AP2005003323A0 (en)	2005-06-30
AP1930A true AP1930A (en)	2008-12-15

Family

ID=34942420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2005003323A AP1930A (en)	2004-09-30	2005-05-31	Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it

Country Status (41)

Country	Link
US (2)	US7459568B2 (es)
EP (2)	EP1642897B9 (es)
JP (2)	JP2006104184A (es)
KR (1)	KR100816590B1 (es)
CN (1)	CN100391956C (es)
AP (1)	AP1930A (es)
AR (1)	AR049395A1 (es)
AT (1)	ATE411308T1 (es)
AU (1)	AU2005202718B2 (es)
BR (1)	BRPI0502228A (es)
CA (1)	CA2508824C (es)
CO (1)	CO5710195A1 (es)
CR (1)	CR7876A (es)
CY (1)	CY1108797T1 (es)
DE (1)	DE602005010359D1 (es)
DK (1)	DK1642897T3 (es)
EA (1)	EA008474B1 (es)
EC (1)	ECSP055859A (es)
ES (1)	ES2314593T3 (es)
FR (1)	FR2875807B1 (es)
GE (1)	GEP20074106B (es)
GT (1)	GT200500130A (es)
HR (1)	HRP20080652T3 (es)
IL (1)	IL169237A (es)
MA (1)	MA27815A1 (es)
MX (1)	MXPA05006407A (es)
NO (1)	NO333948B1 (es)
NZ (1)	NZ540802A (es)
OA (1)	OA13013A (es)
PA (1)	PA8638201A1 (es)
PE (1)	PE20060364A1 (es)
PL (1)	PL1642897T3 (es)
PT (1)	PT1642897E (es)
RS (1)	RS51110B (es)
SA (1)	SA05260168B1 (es)
SG (1)	SG121035A1 (es)
SI (1)	SI1642897T1 (es)
TW (1)	TWI367881B (es)
UA (1)	UA80008C2 (es)
WO (1)	WO2006035122A1 (es)
ZA (1)	ZA200504937B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2875807B1 (fr) *	2004-09-30	2006-11-17	Servier Lab	Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
US20070292535A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating osteoporotic conditions
CN101206208B (zh) *	2006-12-19	2011-08-10	北京德众万全药物技术开发有限公司	一种用hplc法分析雷尼酸锶原料及其制剂的方法
EP2346846A1 (en)	2008-09-29	2011-07-27	Ratiopharm GmbH	Anhydrate and hydrate forms of strontium ranelate
IT1398542B1 (it)	2010-03-05	2013-03-01	Chemelectiva S R L	Processo per la preparazione di un polimorfo
CN102241663B (zh) *	2010-05-10	2013-02-13	山东方明药业集团股份有限公司	一种雷奈酸锶八水合物的制备方法
WO2012143932A1 (en) *	2011-04-21	2012-10-26	Shilpa Medicare Limited	Crystalline strontium ranelate form-s
CZ2011320A3 (cs)	2011-05-30	2012-12-12	Zentiva, K.S.	Stabilní krystalická forma X stroncium ranelátu
EP2530068A1 (en)	2011-05-31	2012-12-05	Lacer, S.A.	New strontium salts, synthesis and use thereof in the treatment of osteoporosis
US9301945B2 (en)	2011-07-21	2016-04-05	Emory University	Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102503931A (zh) *	2011-09-20	2012-06-20	浙江华海药业股份有限公司	一种雷尼酸锶晶形h的制备方法
WO2013113319A1 (en) *	2012-01-31	2013-08-08	Pharmathen S.A.	Process for the preparation of strontium ranelate, intermediate or hydrates thereof
EP2641905A1 (en)	2012-03-23	2013-09-25	Urquima S.A.	Solid forms of strontium ranelate and processes for their preparation
US8569514B1 (en)	2012-05-17	2013-10-29	Divi's Laboratories, Ltd.	Process for the preparation of strontium ranelate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0415850A1 (fr) *	1989-09-01	1991-03-06	Adir Et Compagnie	Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0813869A1 (fr) *	1996-06-17	1997-12-29	Adir Et Compagnie	Utilisation de sels de strontium pour le traitement de l'arthrose
WO2004029036A1 (fr) *	2002-09-24	2004-04-08	Les Laboratoires Servier	Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ272608A (en)	1994-07-22	2000-05-26	Lilly Co Eli	Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts
DE19642451A1 (de)	1996-10-15	1998-04-16	Merck Patent Gmbh	Aminothiophencarbonsäureamide
WO2003028665A2 (en) *	2001-10-03	2003-04-10	Teva Pharmaceutical Industries Ltd.	Methods for the purification of levofloxacin
JP4508646B2 (ja) *	2002-01-09	2010-07-21	エミスフェアー・テクノロジーズ・インク	４−［（４−クロロ−２−ヒドロキシベンゾイル）アミノ］ブタン酸ナトリウムの多形体
US7396839B2 (en) *	2002-08-06	2008-07-08	Teva Pharmaceuticals Usa, Inc.	Crystalline forms of gatifloxacin
FR2844797B1 (fr)	2002-09-24	2004-10-22	Servier Lab	Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr)	2002-09-24	2004-03-26	Servier Lab	Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2875807B1 (fr) *	2004-09-30	2006-11-17	Servier Lab	Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

2004
- 2004-09-30 FR FR0410335A patent/FR2875807B1/fr not_active Expired - Fee Related
2005
- 2005-05-24 PE PE2005000574A patent/PE20060364A1/es not_active Application Discontinuation
- 2005-05-26 MA MA28300A patent/MA27815A1/fr unknown
- 2005-05-27 GT GT200500130A patent/GT200500130A/es unknown
- 2005-05-30 CA CA002508824A patent/CA2508824C/fr not_active Expired - Fee Related
- 2005-05-31 AP AP2005003323A patent/AP1930A/xx active
- 2005-05-31 US US11/140,822 patent/US7459568B2/en not_active Expired - Fee Related
- 2005-06-02 OA OA1200500169A patent/OA13013A/fr unknown
- 2005-06-14 AR ARP050102423A patent/AR049395A1/es not_active Application Discontinuation
- 2005-06-15 SA SA05260168A patent/SA05260168B1/ar unknown
- 2005-06-15 MX MXPA05006407A patent/MXPA05006407A/es active IP Right Grant
- 2005-06-15 CR CR7876A patent/CR7876A/es not_active Application Discontinuation
- 2005-06-16 IL IL169237A patent/IL169237A/en not_active IP Right Cessation
- 2005-06-16 CN CNB2005100753929A patent/CN100391956C/zh not_active Expired - Fee Related
- 2005-06-16 CO CO05058754A patent/CO5710195A1/es not_active Application Discontinuation
- 2005-06-16 EC EC2005005859A patent/ECSP055859A/es unknown
- 2005-06-17 PT PT05291297T patent/PT1642897E/pt unknown
- 2005-06-17 NO NO20052998A patent/NO333948B1/no not_active IP Right Cessation
- 2005-06-17 BR BRPI0502228-2A patent/BRPI0502228A/pt not_active IP Right Cessation
- 2005-06-17 ES ES05291297T patent/ES2314593T3/es not_active Expired - Lifetime
- 2005-06-17 UA UAA200505970A patent/UA80008C2/uk unknown
- 2005-06-17 SI SI200530490T patent/SI1642897T1/sl unknown
- 2005-06-17 DE DE602005010359T patent/DE602005010359D1/de not_active Expired - Lifetime
- 2005-06-17 EP EP05291297A patent/EP1642897B9/fr not_active Revoked
- 2005-06-17 EP EP08007270A patent/EP1944302A1/fr not_active Withdrawn
- 2005-06-17 NZ NZ540802A patent/NZ540802A/en not_active IP Right Cessation
- 2005-06-17 TW TW094120331A patent/TWI367881B/zh not_active IP Right Cessation
- 2005-06-17 GE GEAP20058848A patent/GEP20074106B/en unknown
- 2005-06-17 JP JP2005177199A patent/JP2006104184A/ja active Pending
- 2005-06-17 AU AU2005202718A patent/AU2005202718B2/en not_active Ceased
- 2005-06-17 DK DK05291297T patent/DK1642897T3/da active
- 2005-06-17 WO PCT/FR2005/001515 patent/WO2006035122A1/fr not_active Ceased
- 2005-06-17 PL PL05291297T patent/PL1642897T3/pl unknown
- 2005-06-17 EA EA200500842A patent/EA008474B1/ru not_active IP Right Cessation
- 2005-06-17 ZA ZA200504937A patent/ZA200504937B/en unknown
- 2005-06-17 SG SG200503938A patent/SG121035A1/en unknown
- 2005-06-17 RS RSP-2008/0506A patent/RS51110B/sr unknown
- 2005-06-17 AT AT05291297T patent/ATE411308T1/de active
- 2005-07-01 PA PA20058638201A patent/PA8638201A1/es unknown
- 2005-07-08 KR KR1020050061542A patent/KR100816590B1/ko not_active Expired - Fee Related
2008
- 2008-08-12 US US12/228,381 patent/US7745482B2/en not_active Expired - Fee Related
- 2008-11-19 CY CY20081101327T patent/CY1108797T1/el unknown
- 2008-12-16 HR HR20080652T patent/HRP20080652T3/xx unknown
2010
- 2010-01-07 JP JP2010001847A patent/JP2010132669A/ja active Pending

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0415850A1 (fr) *	1989-09-01	1991-03-06	Adir Et Compagnie	Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0813869A1 (fr) *	1996-06-17	1997-12-29	Adir Et Compagnie	Utilisation de sels de strontium pour le traitement de l'arthrose
WO2004029036A1 (fr) *	2002-09-24	2004-04-08	Les Laboratoires Servier	Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Also Published As

Publication number	Publication date
ATE411308T1 (de)	2008-10-15
NO20052998D0 (no)	2005-06-17
AR049395A1 (es)	2006-07-26
NO333948B1 (no)	2013-10-28
CN100391956C (zh)	2008-06-04
ECSP055859A (es)	2006-09-18
US20060069271A1 (en)	2006-03-30
PA8638201A1 (es)	2006-05-16
HK1086260A1 (zh)	2006-09-15
US7745482B2 (en)	2010-06-29
PT1642897E (pt)	2008-11-27
HRP20080652T3 (en)	2009-01-31
EP1642897B1 (fr)	2008-10-15
JP2006104184A (ja)	2006-04-20
CN1754878A (zh)	2006-04-05
DK1642897T3 (da)	2009-01-26
KR20060049966A (ko)	2006-05-19
ES2314593T3 (es)	2009-03-16
ZA200504937B (en)	2006-04-26
GEP20074106B (en)	2007-05-10
AU2005202718A1 (en)	2006-04-13
CY1108797T1 (el)	2014-04-09
SA05260168B1 (ar)	2009-02-25
KR100816590B1 (ko)	2008-03-24
IL169237A (en)	2010-12-30
PL1642897T3 (pl)	2009-04-30
JP2010132669A (ja)	2010-06-17
CO5710195A1 (es)	2006-12-29
BRPI0502228A (pt)	2006-05-09
OA13013A (fr)	2006-11-10
FR2875807B1 (fr)	2006-11-17
CA2508824C (fr)	2009-03-24
AU2005202718B2 (en)	2010-09-16
EA008474B1 (ru)	2007-06-29
TWI367881B (en)	2012-07-11
EP1642897B9 (fr)	2009-08-12
AP2005003323A0 (en)	2005-06-30
MXPA05006407A (es)	2006-04-05
DE602005010359D1 (de)	2008-11-27
EP1642897A1 (fr)	2006-04-05
UA80008C2 (uk)	2007-08-10
TW200610758A (en)	2006-04-01
NZ540802A (en)	2006-11-30
EP1944302A1 (fr)	2008-07-16
WO2006035122A1 (fr)	2006-04-06
US20080312314A1 (en)	2008-12-18
PE20060364A1 (es)	2006-06-17
RS51110B (sr)	2010-10-31
MA27815A1 (fr)	2006-04-03
NO20052998L (no)	2006-03-31
SG121035A1 (en)	2006-04-26
GT200500130A (es)	2005-12-20
EA200500842A1 (ru)	2006-04-28
US7459568B2 (en)	2008-12-02
FR2875807A1 (fr)	2006-03-31
CR7876A (es)	2007-12-10
SI1642897T1 (sl)	2009-02-28
CA2508824A1 (fr)	2006-03-30

Publication	Publication Date	Title
IL173959A0 (en)	2006-07-05	?? crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SG131857A1 (en)	2007-05-28	δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
SG130110A1 (en)	2007-03-20	New crystalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it
SG130111A1 (en)	2007-03-20	New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it
ZA200601762B (en)	2007-04-25	ß-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
TWI315306B (en)	2009-10-01	Bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
IL178544A (en)	2017-04-30	Crystalline form - δ of ivabradine hydrochloride, process for preparation and pharmaceutical preparations containing it
SI1695709T1 (sl)	2008-10-31	Gama-d kristalna oblika hidroklorida ivabradina, postopek za njegovo pripravo in farmacevtski sestavki, ki ga vsebujejo
AP1930A (en)	2008-12-15	Alpha crystalline form of strontium ranelate, a process for its preparation and pharmaceutical compositions containing it
SG130112A1 (en)	2007-03-20	New crystalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it
SG109010A1 (en)	2005-02-28	New heterocyclic oxime compounds, a process for their preparation and pharmaceutical compositions containing them
IL179530A0 (en)	2007-05-15	Novel compounds, pharmaceutical compositions containing same and methods of use for same
SG126113A1 (en)	2006-10-30	Indany-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
SG121999A1 (en)	2006-05-26	New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
SG110170A1 (en)	2005-04-28	New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
IL178620A0 (en)	2007-02-11	Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them
SG122000A1 (en)	2006-05-26	New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
AU2006200854B2 (en)	2011-02-17	bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
AU2006200857B2 (en)	2011-02-17	y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it